Vivos Therapeutics, Inc. (VVOS): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$15.26M

Year ended 2025-12-31

-$17.13M

Trailing 12 months to 2026-06-30

2019-12-31 Operating Cash Flow (USD) 2025-12-31

Period ended	Operating Cash Flow	Change YoY	Source filing
2025-12-31	-$15.26M	n/m	2026-04-15, From 2025-01-01
2024-12-31	-$12.69M	n/m	2026-04-15, From 2024-01-01
2023-12-31	-$11.95M	n/m	2025-03-31, From 2023-01-01
2022-12-31	-$19.59M	n/m	2024-07-30, From 2022-01-01
2021-12-31	-$15.73M	n/m	2023-03-30, From 2021-01-01
2020-12-31	-$5.68M	n/m	2022-03-31, From 2020-01-01
2019-12-31	-$5.34M	n/a	2021-03-25, From 2019-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Operating Cash Flow	Change YoY
Vivos Therapeutics, Inc. (VVOS)	2025-12-31	-$15.26M	n/m
Nephros Inc (NEPH)	2025-12-31	$1.60M	n/m
Profound Medical Corp. (PROF)	2025-12-31	-$38.21M	n/m
Biotricity Inc. (BTCY)	2026-03-31	-$719.0K	n/m
Sonoma Pharmaceuticals, Inc. (SNOA)	2026-03-31	-$3.93M	n/m
Spectral AI, Inc. (MDAI)	2025-12-31	-$9.92M	n/m
Allurion Technologies, Inc. (ALUR)	2025-12-31	-$28.95M	n/m
DarioHealth Corp. (DRIO)	2025-12-31	-$25.94M	n/m
Baird Medical Investment Holdings Ltd (BDMD)	2025-12-31	-$1.34M	n/m

Compare VVOS, NEPH, PROF, BTCY side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗